Evidence map›Paper›PMID 23066738›Full record

ArticleHelicobacter2012

Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?

Francesco Franceschi, Nicoletta Di Simone, Silvia D'Ippolito, Roberta Castellani, Fiorella Di Nicuolo, Giovanni Gasbarrini, Yoshio Yamaoka, Tullia Todros, Giovanni Scambia, Antonio Gasbarrini

Abstract read
In one paragraph

Article in Helicobacter, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. A Comprehensive Survey of the Relationship betweenArchives of Iranian medicine · 2022
    Pooled it
  2. Systematic Review of Mendelian Randomization Studies onInterdisciplinary perspectives on infectious diseases · 2025
    Review
  3. Article
  4. Article
  5. Preeclampsia in the Context of COVID-19: Mechanisms, Pathophysiology, and Clinical Outcomes.American journal of reproductive immunology (New York, N.Y. : 1989) · 2024
    Review
  6. Causal associations betweenFrontiers in cellular and infection microbiology · 2024
    Article
  7. Review
  8. Evaluating the relationship betweenAnnals of medicine and surgery (2012) · 2021
    Article
  9. The effects ofAnnals of translational medicine · 2021
    Article
  10. Relationship BetweenInternational journal of general medicine · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Barriers and Challenges in Hyperemesis Gravidarum Research.Nutrition and metabolic insights · 2015
    Review
  18. Review
  19. Review
  20. Helicobacter pylori and pregnancy-related disorders.World journal of gastroenterology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Francesco FranceschiEmergency Department, Catholic University of the Sacred Heart, Rome, Italy. francesco.franceschi@rm.unicatt.it
Nicoletta Di Simone
Silvia D'Ippolito
Roberta Castellani
Fiorella Di Nicuolo
Giovanni Gasbarrini
Yoshio Yamaoka
Tullia Todros
Giovanni Scambia
Antonio Gasbarrini
Università Cattolica del Sacro Cuore · ITBologna Research Area · ITMichael E. DeBakey VA Medical Center · USUniversity of the Sacred Heart · JPUniversity of Turin · IT

Funding

REGULATION OF CXC CHEMOKINE EXPRESSION BY H. PYLORIR01DK062813 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI YAMAOKA, YOSHIO · 2004 to 2013
$3.0M
NIDDK NIH HHS R01 DK062813
6 · The paper itself

Abstract

backgroundPrevious studies reported an epidemiological association between CagA-positive H. pylori strains and pre-eclampsia. As antibodies anti-CagA cross-react with endothelial cells and trophoblast cells show an endothelial phenotypic profile, we hypothesized that anti-CagA antibodies may recognize antigens of cytotrophoblast cells, thus impairing their function. MATERIALS AND

methodsPlacenta samples were obtained from healthy women. Cytotrophoblast cells were cultured in a medium containing increasing concentration of polyclonal anti-CagA antibodies. Binding of anti-CagA antibodies to cytotrophoblast cells was evaluated by cell ELISA and immunofluorescence assay. Invasive potential of those cells was assessed by an invasion culture system and by measuring of MMP-2. Protein sequencing was performed on antigens precipitated by anti-CagA antibodies. Measurement of phosphorylated ERK expression and NF-kB DNA-binding activity in trophoblast cells incubated with anti-CagA or irrelevant antibodies was also performed.

resultsAnti-CagA antibodies recognized β-actin of cytotrophoblast cells, showing a dose-dependent binding. Incubation of cytotrophoblast cells with increasing doses of anti-CagA antibodies significantly reduced their invasiveness and determined a significant decrease in phosphorylated ERK expression and a reduced NF-kB translocation activity.

conclusionsThis study shows that anti-CagA antibodies recognize β-actin of cytotrophoblast cells, reducing their invasiveness ability, possibly giving a biological explanation for the epidemiological association.

Indexed as

Cross ReactionsActinsAntibodies, BacterialAntigens, BacterialBacterial ProteinsCells, CulturedEnzyme-Linked Immunosorbent AssayFemaleFluorescent Antibody TechniqueHumansPre-EclampsiaPregnancyRisk FactorsTrophoblastsActinsAntibodies, BacterialAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pylori

Identifiers

PMID23066738
PMCPMC3739447
OpenAlexW1966329208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.